Dinuclear Pt(II) Complex Turn-On Luminescence for DNAse I Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting DNAse I activity are time-consuming, labor-intensive, and often rely on costly fluorophore-labelled DNA, with label-free assays suffering from reduced sensitivity and false positives due to 'turn-off' fluorescence signalling, limiting their utility in high-throughput applications.

Innovation Solution

A label-free, turn-on luminescence assay using a dinuclear Pt(II) complex that exhibits near-IR aggregation-induced emission, which is quenched upon binding to G-quadruplex DNA and restored upon DNA degradation by DNAse I, allowing for sensitive and rapid detection of DNAse I activity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If fluorophore-labelled DNA is used for DNAse I detection, then sensitivity is improved, but cost and synthetic complexity increase

Engineering Contradiction:
Improvedetection sensitivityVSAvoidsynthetic complexity
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The patent replaces expensive fluorophore-labelled DNA with a disposable, pre-formed G-quadruplex DNA structure that can be synthesized once and stored. This G-quadruplex DNA serves as a reusable probe that binds to the Pt(II) complex, eliminating the need for costly fluorophore labelling while maintaining detection sensitivity through the aggregation-induced emission mechanism.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent changes the detection mechanism from fluorophore-based fluorescence to Pt(II) complex-based aggregation-induced emission. This parameter change involves switching from molecular fluorescence to supramolecular emission, where the Pt(II) complex exhibits enhanced emission when aggregated on the G-quadruplex DNA surface, providing sensitivity comparable to fluorophore methods without the synthetic complexity.

Inventive Principle:
Principle #35Parameter changes

2Ease of operation

If turn-off fluorescence signalling is used in label-free assays, then ease of operation is improved, but measurement precision deteriorates due to false positives

Engineering Contradiction:
Improveassay simplicityVSAvoiddetection accuracy
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent inverts the traditional turn-off fluorescence approach by implementing a turn-on emission mechanism. Instead of starting with fluorescent probes that lose signal upon DNA binding, the system uses non-emissive Pt(II) complexes in solution that gain emission when aggregated on G-quadruplex DNA. This inversion eliminates false positives while maintaining operational simplicity, as the signal only appears when the specific DNA-probe interaction occurs.

Inventive Principle:
Principle #13The other way round (Inversion)

Solution Approach 2:

The patent utilizes a phase transition-like behavior where the Pt(II) complex transitions from a monomeric, non-emissive state in solution to an aggregated, emissive state when bound to G-quadruplex DNA. This aggregation-induced emission transition provides a clear, unambiguous signal that avoids the false positive problems associated with turn-off fluorescence, while the transition is easily monitored and the assay remains simple to perform.

Inventive Principle:
Principle #36Phase transitions

3Measurement precision

If conventional ELISA methods are used for DNAse I detection, then measurement precision is improved, but productivity deteriorates due to time-consuming procedures

Engineering Contradiction:
Improvedetection accuracyVSAvoidassay speed
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent replaces the mechanical and chemical complexity of ELISA procedures with a direct optical detection method. Instead of requiring multiple steps including antibody binding, substrate addition, and colorimetric development, the system uses a single-step luminescence measurement where the Pt(II) complex-G-quadruplex assembly provides a direct readout of DNAse I activity. This substitution of the detection mechanism maintains precision while dramatically increasing throughput and reducing assay time.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent extracts the essential detection function from the complex ELISA procedure, isolating the key measurement step. By removing unnecessary steps such as multiple washes, substrate incubations, and colorimetric reactions, the assay focuses on the critical event of DNAse I-mediated DNA cleavage, which is directly reported by the luminescence signal. This extraction of the core function maintains detection accuracy while eliminating time-consuming procedural elements.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The assay provides a fast, cost-effective, and sensitive method for detecting DNAse I activity down to 0.002 U/mL, suitable for high-throughput screening and identification of DNAse I inhibitors, with broad potential for real-time assays of other nucleases and enzymes regulating DNA topology.

Implementation Method 1

A label-free, turn-on luminescence assay using a dinuclear Pt(II) complex that exhibits near-IR aggregation-induced emission

Methodology Applied
Scientific EffectAggregation-induced emission: Luminescence

Implementation Method 2

which is quenched upon binding to G-quadruplex DNA and restored upon DNA degradation by DNAse I

Methodology Applied
Scientific EffectFluorescence quenching: Fluorescence

Data Source

PatentUS11851447B2Dinuclear platinum(II) compounds and methods of use thereof
Publication Date: 2023.12.26 THE UNIVERSITY OF IOWA RESEARCH
  • US11851447B2 patent drawing
  • US11851447B2 patent drawing
  • US11851447B2 patent drawing

AI summary

The invention provides a compound of formula (Ia) or (Ib):or a salt thereof, wherein A, B, C, D, E, F, J, K, L, M, Q, V, X, Y, W and Z have any of the values described in the specification, as well as compositions comprising a compound of formula (Ia) or (Ib) or a salt thereof, and methods of use thereof.